WilmerHale Advises BioCatch in $145 Million Series C Funding

WilmerHale Advises BioCatch in $145 Million Series C Funding

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.
Critical industry insight and formidable strength across key practices.

On April 15, 2020, BioCatch, the global leader in behavioral biometrics, announced that it completed a $145 million Series C investment led by Bain Capital Tech Opportunities. The investment will accelerate BioCatch’s rapid growth, broaden its product offerings and further support its expanding client base into new verticals.

The WilmerHale team representing BioCatch was led by Stephanie Evans and David Haber, and included Michael Bevilacqua, William Caporizzo, Jay Holtmeier, Barry Hurewitz, Scott Kilgore, Chavi Keeney Nana, Evan Kirsch, Tyler Rostock, Chanda Brown and Alex Bernstein.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel